Cardiovascular disease in patients with chronic kidney disease: a neglected subgroup.

about

High Burden of Unrecognized Atrial Fibrillation in Rural India: An Innovative Community-Based Cross-Sectional Screening Program.

P2860

Q37373437-62EB89B8-E345-41DE-9A45-19D4EB6D5021

P2860

Cardiovascular disease in patients with chronic kidney disease: a neglected subgroup.

Item

http://www.wikidata.org/entity/Q37463969

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Cardiovascular disease in patients with chronic kidney disease: a neglected subgroup.

@en

Cardiovascular disease in patients with chronic kidney disease: a neglected subgroup.

@nl

type

Item

label

Cardiovascular disease in patients with chronic kidney disease: a neglected subgroup.

@en

Cardiovascular disease in patients with chronic kidney disease: a neglected subgroup.

@nl

prefLabel

Cardiovascular disease in patients with chronic kidney disease: a neglected subgroup.

@en

Cardiovascular disease in patients with chronic kidney disease: a neglected subgroup.

@nl

P1476

Cardiovascular disease in patients with chronic kidney disease: a neglected subgroup.

@en

P2093

Arun Kumar Subbiah

http://www.w3.org/2001/XMLSchema#string

Sandeep Mahajan

http://www.w3.org/2001/XMLSchema#string

Yogesh K Chhabra

http://www.w3.org/2001/XMLSchema#string

P2860

Antiplatelet agents for chronic kidney disease

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease

Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Angiotensin-converting enzyme inhibitor, angiotensin receptor blocker use, and mortality in patients with chronic kidney disease.

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

Association between chronic kidney disease progression and cardiovascular disease: results from the CRIC Study.

Cardiac troponins in renal insufficiency: review and clinical implications.

Cardiovascular risk in chronic kidney disease.

P304

56-61

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/HEARTASIA-2016-010809

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27933104

http://www.w3.org/2001/XMLSchema#string

P932

5133395

http://www.w3.org/2001/XMLSchema#string

Cardiovascular disease in patients with chronic kidney disease: a neglected subgroup.

about

P2860

P2860

Cardiovascular disease in patients with chronic kidney disease: a neglected subgroup.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932